Evidence map›Paper›PMID 30065109›Full record

ReviewBiochemical Society transactions2018

Emerging mechanisms of dynein transport in the cytoplasm versus the cilium.

Anthony J Roberts

Open access · hybridAbstract readReview
In one paragraph

Review in Biochemical Society transactions, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Specific kinesin and dynein molecules participate in the unconventional protein secretion of transmembrane proteins.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. The global transcriptome ofMicrobiology spectrum · 2023
    Article
  15. Article
  16. Deficiency ofFrontiers in cell and developmental biology · 2023
    Article
  17. Characterization of a novel deep-intronic variant inCold Spring Harbor molecular case studies · 2022
    Article
  18. Article
  19. NovelThe world journal of men's health · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Anthony J RobertsInstitute of Structural and Molecular Biology, Birkbeck, University of London, Malet Street, London, U.K. a.roberts@mail.cryst.bbk.ac.uk.
Birkbeck, University of London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/P008348/1Wellcome Trust 104196/Z/14/Z
6 · The paper itself

Abstract

Two classes of dynein power long-distance cargo transport in different cellular contexts. Cytoplasmic dynein-1 is responsible for the majority of transport toward microtubule minus ends in the cell interior. Dynein-2, also known as intraflagellar transport dynein, moves cargoes along the axoneme of eukaryotic cilia and flagella. Both dyneins operate as large ATP-driven motor complexes, whose dysfunction is associated with a group of human disorders. But how similar are their mechanisms of action and regulation? To examine this question, this review focuses on recent advances in dynein-1 and -2 research, and probes to what extent the emerging principles of dynein-1 transport could apply to or differ from those of the less well-understood dynein-2 mechanoenzyme.

Indexed as

Adenosine TriphosphateAxonemeCiliaCytoplasmDyneinsProtein TransportAdenosine TriphosphateDyneinsciliadyneinintraflagellar transportkinesinmicrotubule

Identifiers

PMID30065109
PMCPMC6103457
OpenAlexW2885297363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.